# Handoff: bio-clinical-biostatistics-adaptive-designs / audit-scientific-skill

- Updated: 2026-09-28T21:20:00Z
- Lane: 1
- Status: ready-for-phase
- Owner leaving: /root/lane1_adaptive_audit
- Next role: fix-scientific-skill

## Source identity

- Origin: `GPTomics/bioSkills@d91ed3d563019e649dc854c56ccd62551359488a:clinical-biostatistics/adaptive-designs`; source subtree `85188936f8fee497db8c92c095bcbd0a888e376e`.
- Candidate: `F:\OpenScience\wt\opt10-adaptive-designs\skills\bio-clinical-biostatistics-adaptive-designs` on `optimize/ten-20260928-lane1-adaptive-designs` at HEAD `0bc0b31fc52742dbec1034f698103434cc9460c3`.
- Exact audited identity: `sha256-manifest-v1:73116b86978447d18f14945b236561b0685796da68f1a993420352c3c6953546` (8 files; 764 manifest bytes).
- Immutable identity record: `F:\OpenScience\audits\bio-clinical-biostatistics-adaptive-designs\initial-opt10-20260928\source-identity.json` (SHA-256 `121fe8d11f41658803f4630f0af1d3b4e4f88c8ca6d92e1f2cd5af5ad4750808`).

## Completed this phase

- Read the retained `skill-auditor@1.0` rubric and independently audited the complete exact candidate with no audit-local repair.
- Re-ran all candidate sections in the prepared isolated WSL boundary: 1/2/4/5 pass; 3/6/8 error; 7/9/10 are documented-only. The shipped full script exits `1` at section 3.
- Re-ran the current-interface control harness: 9/9 pass for gsDesign/gsSurv, rpact, BOIN, dfcrm, RBesT, gsDesign2, simtrial, adaptr, and invalid-input contracts.
- Adjudicated current authoritative FDA status: 2019 adaptive guidance final; 2022 oncology master-protocol guidance final; September 2025 ICH E20 FDA draft; January 2026 Bayesian draft; June 2026 broader master-protocol revised draft; BOIN remains Fit-for-Purpose, not generally FDA-preferred.
- Produced a schema-valid diagnostic report: static `71/100`, dynamic `50.4/100`, assertions `18/35`, final `59/100 Reject`; structural veto FAIL (stability, determinism) and research veto FAIL (methodological ground, code usability).
- Raw record: `F:\OpenScience\audits\bio-clinical-biostatistics-adaptive-designs\initial-opt10-20260928`; `report.json` SHA-256 `9c930743e3ba6071f35eb83ef0c02c256856e3c488f51d5c7430c63db041d544`; `viewer.md` SHA-256 `3ee96561170583eab1f6cacf3be94a9d18d98f632b6c624f77097ad16d4c9648`.

## Required next actions

1. Fix all P0 and P1 findings in order without widening scientific scope: repair current rpact fixed-design SSR, align and validate CRM grids, implement true EXNEX or relabel MAP, seed stochastic runs, complete or demote promising-zone execution, and qualify Type-I language.
2. Address P2 regulatory wording while touching the relevant files: remove the FDA-preference claim and distinguish the 2022 oncology final guidance, June 2026 broader draft, ICH Step 2 milestone, and September 2025 FDA draft issue date.
3. Recompute a new exact candidate identity and route to fresh delta tooling; do not treat the valid-control harness as a candidate fix.
4. After delta tooling passes, route the new exact bytes to a fresh independent `reaudit-scientific-skill` worker. Do not publish this raw audit from the fixer role.

## Open findings and blockers

| ID | Severity | State | Evidence | Required disposition |
|---|---|---|---|---|
| ADAPT-001 | P0 | open | `report.json` input 2; `evidence/section-03.json` | Replace incompatible fixed `asUser` contract; execute and assert both blinded-SSR sample sizes. |
| ADAPT-002 | P0 | open | input 5; `evidence/section-06.json` | Align six-dose CRM truth/skeleton, validate dimensions before simulation, and make result printable. |
| ADAPT-003 | P0 | open | input 6; `evidence/section-08.json` | Implement actual EXNEX/robust detachment plus current RBesT density conversion, or relabel the method. |
| ADAPT-004 | P1 | open | inputs 4-6; `evidence/valid-api-smoke.json` | Set/report seeds and add deterministic schema/tolerance assertions. |
| ADAPT-005 | P1 | open | input 3; candidate section 4 | Implement conditional power, adaptation, `n_max`, original weights, and null calibration, or mark documented-only. |
| ADAPT-006 | P1 | open | input 2; candidate section 3 | Replace unconditional Type-I guarantee with method conditions and evidence. |
| ADAPT-007 | P2 | open | input 4; candidate section 5 | Replace “FDA prefers BOIN” with exact Fit-for-Purpose status. |
| ADAPT-008 | P2 | open | `scientific-source-notes.md` | Refresh current master-protocol and ICH E20 status routing. |
| OPTIONAL-ADAPT-001 | P3 | bounded | `evidence/optional-package-classification.md` | `trialr`/`escalation` remain unavailable after the bounded ceiling; extend only if future audit scope requires them. |
| ACCESS-ADAPT-001 | P3 | blocked | `evidence/TOOLS.md` | East/EastHorizon, ADDPLAN, and FACTS require legitimately supplied licenses/binaries; no bypass is permitted. |

## Environment and evidence

- Tooling inventory: `F:\OpenScience\audit-envs\bio-clinical-biostatistics-adaptive-designs\TOOLS.md` (SHA-256 `429d5bb80ad823427b285b5b34eb36d8bf2d4179bfbc66e81a8ec9f210dd7f09`).
- Exact lock: sibling `environment-explicit.lock` (SHA-256 `5f0bb3bca2660982c18770fd76ac9deffbd6157c5bd4db55f46c1c1d69aa230c`); environment fingerprint SHA-256 `f5d8518ba132b9e31b0c592534e241b3d1ab7af5b3186f9a4909b22f5573592c`.
- Audit artifacts: `report.json`, `viewer.md`, `finding-ledger.md`, `inputs.json`, `execution-classifications.json`, `scientific-source-notes.md`, `commands.txt`, `artifact-hashes.tsv`, and `evidence/schema-validation.json` (`PASS`).
- Execution evidence: `evidence/candidate-section-status.tsv`, `evidence/section-01.json` through `section-10.json`, `evidence/full-script.log`, and `evidence/valid-api-smoke.json` (`all_passed: true` for the independent controls).
- Deferred surfaces: sections 7/9/10 are responsibly documented-only and cannot support readiness; optional `trialr`/`escalation` are bounded unavailable; commercial tools are restricted documented-only.

## Worktree safety

- Product worktree status remains only `?? skills/bio-clinical-biostatistics-adaptive-designs/`; the audited candidate bytes still hash to the exact normalization identity.
- Audit writes are confined to the raw run root and this canonical handoff. No candidate file was repaired or edited.
- The exact audit was published locally as `candidate@73116b869784-initial-opt10-20260928` with 44 explicit scripts/inputs; generated views were refreshed. The matching record/view/handoff changes await the run-owned control commit. No product commit, push, pull request, release, Marketplace action, dependency installation, or licensed-tool bypass occurred.

## Transition assertion

- Next-phase prerequisites met: yes
- If no: n/a
